- New Chief Executive Officer, Martin Fitchet MD, brings over 25 years of experience throughout Drugs, MedTech and Public Health
- Martin was most lately at Johnson & & Johnson, where he was the International Head of Global Public Wellness and likewise held several management functions in R&D
- His confirmed record at Johnson & & Johnson straightens flawlessly with MMV’s goal and future strategy
Medicines for Jungle fever Endeavor (MMV), a leading not-for-profit collaboration committed to combating jungle fever, has today introduced the visit of Martin Fitchet MD as its brand-new President (CHIEF EXECUTIVE OFFICER).
Martin brings over 25 years of experience throughout Drugs, MedTech and Global Public Wellness and signs up with from Johnson & & Johnson where he was most lately the International Head of Global Public Health And Wellness. Before that, Martin held several substantial management functions at Johnson & & Johnson, pioneering the growth of and international accessibility to unique drugs for cardio and metabolic illness, HIV, consumption, Ebola and Covid-19.
The brand-new chief executive officer signs up with as MMV commemorates its 25th wedding anniversary and is successful David Reddy, that went to the helm of the organisation for 13 years. Throughout this duration, MMV advanced 15 brand-new medications estimated to have saved the lives of 15.4 million people. Yet jungle fever stays an immediate and pushing international wellness concern that takes greater than 600,000 lives a year. We need to get over the obstacles positioned by medication resistance, environment modification and breakable wellness systems that restrict accessibility to medications by the most prone, significantly youngsters and expectant females.
In his brand-new function, Martin will certainly manage the growth and distribution of brand-new antimalarial medications to aid attain a malaria-free future. This vision of the future is the cornerstone of MMV’s brand-new 2024-2030 technique that will certainly be gone for the Multilateral Campaign on Jungle fever Culture Meeting happening in Rwanda from 21— 27 April. The technique sets out 4 columns and cross-cutting concerns that will certainly identify the organisation’s task in the years in advance.
Martin Fitchet MD, Chief Executive Officer of MMV, claimed:
” I am honoured and thrilled to sign up with MMV, at such a crucial time. Particularly, I am influenced by the organisation’s ruthless concentrate on using technology to conserve the lives of prone and under-served populaces in jeopardy of jungle fever. I am dedicated to proceeding this crucial job and excited to start collaborating with the committed MMV group and companions, to speed up initiatives to aid those most afflicted and to inevitably remove this condition.”
Alan Court, MMV Board Chair, claimed:
” MMV’s Board is thrilled that Martin has actually approved the function of leading MMV. He is successful David Reddy, to whom I provide my sincere many thanks for his exceptional management over the last 13 years. Martin’s know-how and tried and tested record of promoting technology and accessibility to medications straighten flawlessly with MMV’s tactical campaigns. I am certain that Martin, as a physician and international wellness leader, will certainly lead the organisation to supply advanced technology to the populaces that require it most.”
